全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Vanishing Lung Syndrome in a Patient with HIV Infection and Heavy Marijuana Use

DOI: 10.1155/2014/285208

Full-Text   Cite this paper   Add to My Lib

Abstract:

Vanishing lung syndrome (VLS) is a rare and distinct clinical syndrome that usually affects young men. VLS leads to severe progressive dyspnea and is characterized by extensive, asymmetric, peripheral, and predominantly upper lobe giant lung bullae. Case reports have suggested an additive role of marijuana use in the development of this disease in young male tobacco smokers. We herein report a case of a 65-year-old Hispanic male previously diagnosed with severe emphysema and acquired immune deficiency syndrome (AIDS), with a history of intravenous heroin use and active marijuana smoking who presents to the emergency department with severe progressive shortness of breath he was found to have multiple large subpleural bullae occupying more than one-third of the hemithorax on chest computerized tomography (CT), characteristic of vanishing lung syndrome. The patient was mechanically ventilated and later developed a pneumothorax requiring chest tube placement and referral for surgical bullectomy. Surgical bullectomy has shown high success rates in alleviating the debilitating symptoms and preventing the life threatening complications of this rare syndrome. This case further emphasizes the importance of recognizing VLS in patients with severe emphysema and heavy marijuana smoking. 1. Introduction Vanishing lung syndrome, also termed giant bullous emphysema (GBE), is a rare syndrome first described by Burke in 1937 [1]. It is an idiopathic and distinct clinical syndrome that affects young men, usually smokers. It causes severe progressive dyspnea and is characterized by extensive, predominantly asymmetric upper lobe bullous emphysema, which may eventually lead to respiratory failure [2]. Case reports have suggested an additive role of marijuana smoking in the development of this disease in young male smokers where tobacco consumption was less than what is commonly associated with the development of emphysema (i.e., less than 20 pack years) [3, 4]. We report a case of a 65-year-old male diagnosed with end stage emphysema for 3 years, AIDS, and a history of heavy marijuana smoking. He presents to the hospital in acute respiratory distress with multiple large peripheral lung bullae on chest CT consistent with vanishing lung syndrome. 2. Case Presentation A 65-year-old Hispanic male was brought to the emergency department due to severe shortness of breath at home. The shortness of breath started approximately one week prior to presentation and had progressively worsened over time. Upon arrival to the emergency department the patient was hypoxemic and in severe

References

[1]  R. Burke, “Vanishing lungs: a case report of bullous emphysema,” Radiology, vol. 28, no. 3, pp. 367–371, 1937.
[2]  G. M. Waitches, E. J. Stern, and T. J. Dubinsky, “Usefulness of the double-wall sign in detecting pneumothorax in patients with giant bullous emphysema,” American Journal of Roentgenology, vol. 174, no. 6, pp. 1765–1768, 2000.
[3]  M. K. Johnson, R. P. Smith, D. Morrison, G. Laszlo, and R. J. White, “Large lung bullae in marijuana smokers,” Thorax, vol. 55, no. 4, pp. 340–342, 2000.
[4]  S. W. Hii, J. D. Tam, B. R. Thompson, and M. T. Naughton, “Bullous lung disease due to marijuana,” Respirology, vol. 13, no. 1, pp. 122–127, 2008.
[5]  N. Sharma, A. M. Justaniah, J. P. Kanne, J. W. Gurney, and T.-L. Mohammed, “Vanishing lung syndrome (giant bullous emphysema): CT findings in 7 patients and a literature review,” Journal of Thoracic Imaging, vol. 24, no. 3, pp. 227–230, 2009.
[6]  G. L. Snider, “Reduction pneumoplasty for giant bullous emphysema. Implications for surgical treatment of nonbullous emphysema,” Chest, vol. 109, no. 2, pp. 540–548, 1996.
[7]  M. Beshay, H. Kaiser, D. Niedhart, M. A. Reymond, and R. A. Schmid, “Emphysema and secondary pneumothorax in young adults smoking cannabis,” European Journal of Cardio-Thoracic Surgery, vol. 32, no. 6, pp. 834–838, 2007.
[8]  D. C. Hutchison, D. Cooper, and British Thoracic Society, “Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials,” Respiratory Medicine, vol. 96, no. 11, pp. 872–880, 2002.
[9]  A. Miller, “The vanishing lung syndrome associated with pulmonary sarcoidosis,” British Journal of Diseases of the Chest, vol. 75, no. 2, pp. 209–214, 1981.
[10]  M. L. Howden and M. T. Naughton, “Pulmonary effects of marijuana inhalation,” Expert Review of Respiratory Medicine, vol. 5, no. 1, pp. 87–92, 2011.
[11]  R. G. Fraser, J. A. P. Pare, P. D. Pare, R. S. Fraser, and G. P. Genereux, Diagnosis of Diseases of the Chest, W.B. Saunders, Philadelphia, Pa, USA, 3rd edition, 1990.
[12]  T.-C. Wu, D. P. Tashkin, B. Dhahed, and J. E. Rose, “Pulmonary hazards of smoking marijuana as compared with tobacco,” The New England Journal of Medicine, vol. 318, no. 6, pp. 347–351, 1988.
[13]  J. L. Azorlosa, M. K. Greenwald, and M. L. Stitzer, “Marijuana smoking: effects of varying puff volume and breathhold duration,” Journal of Pharmacology and Experimental Therapeutics, vol. 272, no. 2, pp. 560–569, 1995.
[14]  J. L. Azorlosa, S. J. Heishman, M. L. Stitzer, and J. M. Mahaffey, “Marijuana smoking: effect of varying 9-tetrahydrocannabinol content and number of puffs,” Journal of Pharmacology and Experimental Therapeutics, vol. 261, no. 1, pp. 114–122, 1992.
[15]  P. T. Diaz, M. A. King, E. R. Pacht et al., “Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers,” Annals of Internal Medicine, vol. 132, no. 5, pp. 369–372, 2000.
[16]  A. Hirani, R. Cavallazzi, T. Vasu et al., “Prevalence of obstructive lung disease in HIV population: a cross sectional study,” Respiratory Medicine, vol. 105, no. 11, pp. 1655–1661, 2011.
[17]  A. Treitinger, C. Spada, J. C. Verdi et al., “Decreased antioxidant defence in individuals infected by the human immunodeficiency virus,” European Journal of Clinical Investigation, vol. 30, no. 5, pp. 454–459, 2000.
[18]  E. J. Stern, W. R. Webb, A. Weinacker, and N. L. Muller, “Idiopathic giant bullous emphysema (vanishing lung syndrome): imaging findings in nine patients,” American Journal of Roentgenology, vol. 162, no. 2, pp. 279–282, 1994.
[19]  G. D. Phillips, B. Trotman-Dickenson, M. E. Hodson, and D. M. Geddes, “Role of CT in the management of pneumothorax in patients with complex cystic lung disease,” Chest, vol. 112, no. 1, pp. 275–278, 1997.
[20]  A. Palla, M. Desideri, G. Rossi et al., “Elective surgery for giant bullous emphysema: a 5-year clinical and functional follow-up,” Chest, vol. 128, no. 4, pp. 2043–2050, 2005.
[21]  R. Neviere, M. Catto, N. Bautin et al., “Longitudinal changes in hyperinflation parameters and exercise capacity after giant bullous emphysema surgery,” The Journal of Thoracic and Cardiovascular Surgery, vol. 132, no. 5, pp. 1203–1207, 2006.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133